Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Alzheimer disease

The search for a blood-based biomarker for Alzheimer disease

Nature Reviews Neurology volume 10, pages 618–619 (2014)Cite this article

Subjects

Finding a peripheral biomarker for early Alzheimer disease (AD) is a major challenge. A recent study has validated a plasma protein signature that is associated with mild cognitive impairment and AD, and could predict conversion; however, longitudinal cohort studies of presymptomatic individuals are needed to confirm the findings.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ray, S. et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 13, 1359–1362 (2007).

    Article  CAS  Google Scholar 

  2. Hye, A. et al. Plasma proteins predict conversion to dementia from prodromal disease. Alzheimers Dement. http://dx.doi.org/10.1016/j.jalz.2014.05.1749.

  3. Villemagne, V. L. et al. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol. 12, 357–367 (2013).

    Article  CAS  Google Scholar 

  4. Hye, A. et al. Proteome-based plasma biomarkers for Alzheimer's disease. Brain 129, 3042–3050 (2006).

    Article  CAS  Google Scholar 

  5. O'Bryant, S. E. et al. A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI. PLoS ONE 6, e28092 (2011).

    Article  CAS  Google Scholar 

  6. Laws, S. M., Doecke, J. D. & Martins, R. N. Blood-based biomarkers in Alzheimer disease: where are we now and where have we to go?—Reply. JAMA Neurol. 70, 133–134 (2013).

    Article  Google Scholar 

  7. Burnham, S. C. et al. A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study. Mol. Psychiatry 19, 519–526 (2014).

    Article  CAS  Google Scholar 

  8. Soares, H. D. et al. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease. Arch. Neurol. 69, 1310–1317 (2012).

    Article  Google Scholar 

  9. Skogstrand, K. Multiplex assays of inflammatory markers, a description of methods and discussion of precautions—our experience through the last ten years. Methods 56, 204–212 (2012).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Florey Institute of Neuroscience and Mental Health, Kenneth Myer Building, 30 Royal Parade, Parkville, Melbourne, 3010, Vic, Australia

    Alan Rembach

Authors
  1. Alan Rembach
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alan Rembach.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rembach, A. The search for a blood-based biomarker for Alzheimer disease. Nat Rev Neurol 10, 618–619 (2014). https://doi.org/10.1038/nrneurol.2014.182

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2014.182

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing